Tag: SPL

Starpharma ASX SPL pancreatic cancer DEP irinotecan oncological diseases clinical trials

Starpharma’s DEP irinotecan candidate has positive impact on human pancreatic cancer in mice

Starpharma (ASX: SPL) reported its DEP irinotecan candidate has induced “complete tumour regression” when trialled on mouse xenograft models with human pancreatic cancer. During the...
Starpharma Agrochemicals ASX SPL Agrium

Starpharma sells Agrochemicals business to Agrium for $35M

Starpharma Holdings (ASX: SPL) has completed a transaction to sell its agrochemicals and Priostar® business (Starpharma Agrochemicals) to Agrium, Inc. (NYSE: AGU, TSE: AGU)...

RECENT POSTS

STOCK SUMMARY

HOT TOPICS

TRENDING POSTS